Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford… - … England Journal of …, 2015 - Mass Medical Soc
Background The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …
falciparum and has partial protective efficacy against clinical and severe malaria disease in …
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford… - The New England …, 2015 - edoc.unibas.ch
The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium falciparum
and has partial protective efficacy against clinical and severe malaria disease in infants and …
and has partial protective efficacy against clinical and severe malaria disease in infants and …
[引用][C] Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
New England Journal of Medicine, 2015 - cmp.ku.dk
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine - Staff Topic
navigation Content Footer links Start Toggle navigation Map Phone Book KUnet Dansk …
navigation Content Footer links Start Toggle navigation Map Phone Book KUnet Dansk …
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
DE Neafsey, M Juraska… - New England …, 2015 - tobias-lib.ub.uni-tuebingen.de
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine Genetic Diversity
and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine DSpace Repositorium (Manakin …
and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine DSpace Repositorium (Manakin …
[HTML][HTML] Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
DE Neafsey, M Juraska, T Bedford… - The New England …, 2015 - ncbi.nlm.nih.gov
BACKGROUND The RTS, S/AS01 vaccine targets the circumsporozoite protein of
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine.
DE Neafsey, M Juraska, T Bedford… - The New England …, 2015 - researchonline.lshtm.ac.uk
BACKGROUND: The RTS, S/AS01 vaccine targets the circumsporozoite protein of
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
[引用][C] Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
DE Neafsey, M Juraska, T Bedford… - New England Journal …, 2015 - cir.nii.ac.jp
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine.
DE Neafsey, M Juraska, T Bedford, D Benkeser… - 2015 - cabidigitallibrary.org
Abstract BACKGROUND: The RTS, S/AS01 vaccine targets the circumsporozoite protein of
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
DE Neafsey, M Juraska, T Bedford… - New England Journal …, 2015 - hero.epa.gov
BACKGROUND: The RTS, S/AS01 vaccine targets the circumsporozoite protein of
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Plasmodium falciparum and has partial protective efficacy against clinical and severe …
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
DE Neafsey, M Juraska, T Bedford… - The New England …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …
falciparum and has partial protective efficacy against clinical and severe malaria disease in …